Cellular Model of Malignant Transformation of Primary Human Astrocytes Induced by Deadhesion/Readhesion Cycles

Author(s)

da S. Soares, Roseli ; de S. Laurentino, Talita ; da Silva, Camila T. ; Goncalves, Jessica D. ; Lerario, Antonio M. ; Marie, Suely K. N. ; Oba-Shinjo, Sueli M. ; Jasiulionis, Miriam G.

• Document type: Journal article
• Source: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; v. 23, n. 9, p. 18-pg., 2022-05-01.

Abstract

Astrocytoma is the most common and aggressive tumor of the central nervous system. Genetic and environmental factors, bacterial infection, and several other factors are known to be involved in gliomagenesis, although the complete underlying molecular mechanism is not fully understood. Tumorigenesis is a multistep process involving initiation, promotion, and progression. We present a human model of malignant astrocyte transformation established by subjecting primary astrocytes from healthy adults to four sequential cycles of forced anchorage impediment (deadhesion). After limiting dilution of the surviving cells obtained after the fourth deadhesion/readhesion cycle, three clones were randomly selected, and exhibited malignant characteristics, including increased proliferation rate and capacity for colony formation, migration, and anchorage-independent growth in soft agar. Functional assay results for these clonal cells, including response to temozolomide, were comparable to U87MG-a human glioblastoma-derived cell lineage-reinforcing malignant cell transformation. RNA-Seq analysis by next-generation sequencing of the transformed clones relative to the primary astrocytes revealed upregulation of genes involved in the PI3K/AKT and Wnt/beta-catenin signaling pathways, in addition to upregulation of genes related to epithelial-mesenchymal transition, and downregulation of genes related to aerobic respiration. These findings, at a molecular level, corroborate the change in cell behavior towards mesenchymal-like cell dedifferentiation. This linear progressive model of malignant human astrocyte transformation is unique in that neither genetic manipulation nor treatment with carcinogens are used, representing a promising tool for testing combined therapeutic strategies for glioblastoma patients, and furthering knowledge of astrocytoma transformation and progression. (AU)

• FAPESP's process: 18/20775-0 - Non-coding RNAs involved with melanoma genesis and progression
• Grantee: Miriam Galvonas Jasiulionis
• Support Opportunities: Regular Research Grants
• FAPESP's process: 21/01207-4 - Functional role of LOXL3 in glioblastoma
• Grantee: Talita de Sousa Laurentino
• Support Opportunities: Scholarships in Brazil - Doctorate